A. Kudelka

Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma.

W. Hittelman, M. Burgess, S. Vadhan-Raj, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.

P. Thall, G. Hortobagyi, R. Giles, 1996, Proceedings of the National Academy of Sciences of the United States of America.

The effects of interleukin-1 therapy on peripheral blood granulocyte function in humans

S. Banks, J. Kavanagh, S. Vadhan-Raj, 2005, Cancer Immunology, Immunotherapy.

Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.

S. Heimfeld, M. Andreeff, R. Giles, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.